Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2Papillomavirus Infections 2Uterine Diseases 1Uterine Cervical Neoplasms 1Neoplasms 1Genital Diseases, Female 1

Interventions

Colposcopy 15Imiquimod 13Conization 11Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Papillomavirus Vaccines 6Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Watchful Waiting 4Human Papillomavirus DNA Tests 4Vaccines 3Blood Specimen Collection 3VGX-3100 2Transurethral Resection of Prostate 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Mass Screening 2Indomethacin 2Human Papillomavirus Recombinant Vaccine nonavalent 2High-Throughput Screening Assays 2GX-188 vaccine 2Fluorouracil 2Flow Cytometry 2Cyclophosphamide 2Curcumin 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Dysplasia × GX-188 vaccine × Clear all
NCT02139267 2017-07-12

Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia

Genexine, Inc.

Phase 2 Completed
72 enrolled
Gynecologic

Uterine Cervical Dysplasia, Genital Diseases, Female, Neoplasms, Uterine Diseases, Papillomavirus Infections

NCT02596243 2017-07-12

Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)

Genexine, Inc.

Phase 2 Unknown
134 enrolled
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡